• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein.

作者信息

Kano M, Matano T, Nakamura H, Takeda A, Kato A, Ariyoshi K, Mori K, Sata T, Nagai Y

出版信息

AIDS. 2000 Jun 16;14(9):1281-2. doi: 10.1097/00002030-200006160-00030.

DOI:10.1097/00002030-200006160-00030
PMID:10894297
Abstract
摘要

相似文献

1
Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein.表达Gag蛋白的重组仙台病毒引发针对猿猴免疫缺陷病毒感染的保护性免疫
AIDS. 2000 Jun 16;14(9):1281-2. doi: 10.1097/00002030-200006160-00030.
2
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.通过具有复制能力的Ad5hr-SIVenv/rev和Ad5hr-SIVgag重组初免/gp120加强方案，增强恒河猴对直肠内猿猴免疫缺陷病毒SIV（mac251）攻击的保护作用。
J Virol. 2003 Aug;77(15):8354-65. doi: 10.1128/jvi.77.15.8354-8365.2003.
3
Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.编码猿猴免疫缺陷病毒gag基因和人类免疫缺陷病毒env基因的5型/35型嵌合腺病毒载体可使猴子对猿猴/人类免疫缺陷病毒产生保护性免疫。
Virology. 2007 Oct 25;367(2):390-7. doi: 10.1016/j.virol.2007.06.012. Epub 2007 Jul 12.
4
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.用猿猴免疫缺陷病毒（SIV）gag DNA疫苗接种的恒河猴在感染致病性SIV后会产生继发性细胞毒性T淋巴细胞反应并控制病毒复制。
J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000.
5
Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control.猿猴免疫缺陷病毒群特异性抗原逃避主要组织相容性复合体I类介导的控制对中枢神经系统产生的后果
J Neurovirol. 2016 Aug;22(4):498-507. doi: 10.1007/s13365-015-0420-5. Epub 2016 Jan 4.
6
Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.静脉接种表达猿猴免疫缺陷病毒gag的复制缺陷型重组痘苗病毒DIs可控制猴体内的高致病性猿猴-人类免疫缺陷病毒。
J Virol. 2003 Dec;77(24):13248-56. doi: 10.1128/jvi.77.24.13248-13256.2003.
7
CD4+ T cell responses to simian immunodeficiency virus.CD4 + T细胞对猴免疫缺陷病毒的反应。
Curr Top Microbiol Immunol. 1994;188:161-73. doi: 10.1007/978-3-642-78536-8_9.
8
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.携带载体的Gag和Env而非Tat在Mamu - A*01阴性恒河猴中对猿猴 - 人类免疫缺陷病毒89.6P攻击显示出有效性。
J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.
9
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge.源自猴免疫缺陷病毒黑猩猩亚种（SIVmne）不同时期分离株的Gag/Pol/Env疫苗针对同源病毒攻击的免疫原性和保护效力
J Med Primatol. 2007 Aug;36(4-5):254-65. doi: 10.1111/j.1600-0684.2007.00243.x.
10
Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.两种重组负链RNA病毒载体诱导针对猿猴免疫缺陷病毒gag的细胞免疫反应
J Virol. 2004 Sep;78(17):9366-75. doi: 10.1128/JVI.78.17.9366-9375.2004.

引用本文的文献

1
Immunogenicity, security and protection against small ruminant lentivirus (SRLV) challenge in sheep, induced by intranasal immunization with a recombinant Sendai virus vector expressing SRLV gag-P25.用表达小反刍兽疫病毒（SRLV）gag - P25的重组仙台病毒载体经鼻内免疫诱导绵羊产生的免疫原性、安全性及对SRLV攻击的保护作用。
Vet Q. 2025 Dec;45(1):1-16. doi: 10.1080/01652176.2025.2556492. Epub 2025 Sep 17.
2
Recombinant Sendai Virus Vectors as Novel Vaccine Candidates Against Animal Viruses.重组仙台病毒载体作为抗动物病毒的新型候选疫苗
Viruses. 2025 May 21;17(5):737. doi: 10.3390/v17050737.
3
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
遗传重编程的进展：从发育生物学到再生医学的前景。
Curr Med Chem. 2024;31(13):1646-1690. doi: 10.2174/0929867330666230503144619.
4
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.鼻内接种具有复制能力的仙台病毒载体1型人类免疫缺陷病毒（HIV-1） gag疫苗的安全性和免疫原性的首次人体评估：在初免-加强免疫方案中诱导强效T细胞或抗体反应
J Infect Dis. 2017 Jan 1;215(1):95-104. doi: 10.1093/infdis/jiw500. Epub 2016 Oct 17.
5
RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.基于 RNA 的核重编程和谱系转换工具：迈向临床应用。
J Cardiovasc Transl Res. 2013 Dec;6(6):956-68. doi: 10.1007/s12265-013-9494-8. Epub 2013 Jul 13.
6
Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.糖基化对基于Env的疫苗在猕猴艾滋病模型中抗猿猴免疫缺陷病毒SIVmac239效力的影响。
J Virol. 2005 Aug;79(16):10386-96. doi: 10.1128/JVI.79.16.10386-10396.2005.
7
Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model.一种艾滋病疫苗在猕猴艾滋病模型中的保护效力：先用单一DNA疫苗初免，再用重组复制缺陷型仙台病毒载体进行单次加强免疫。
J Virol. 2003 Sep;77(17):9710-5. doi: 10.1128/jvi.77.17.9710-9715.2003.
8
Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen.在用DNA初免/仙台病毒载体加强免疫方案接种的猕猴中，高致病性免疫缺陷病毒攻击后，二次免疫反应迅速出现，并免受急性CD4细胞耗竭的影响。
J Virol. 2001 Dec;75(23):11891-6. doi: 10.1128/JVI.75.23.11891-11896.2001.